glp 1 agonist therapy Resmetirom and GLP-1 agonists for MASH: complementary rather than exclusive Frontiers | GLP-1 Receptor Agonists:
Description
2022 Jan 18;107(2):363-378
doi: 10.1161/CIRCULATIONAHA.122.059595 [DOI] [PubMed] [Google Scholar] 3
One in 8 American adults now takes a GLP-1 drug to manage diabetes or obesity
Cantini G, Di Franco A, Samavat J, Forti G, Mannucci E, Luconi M
Most gastroparesis cases (between a quarter and a half) are labeled as idiopathic, which means healthcare providers couldnt determine the cause
The multifaceted role of GLP-1 in metabolic disorders, chronic inflammation, and aging: Mechanisms and therapeutic potential
